 |
市场调查报告书
商品编码
1629625
镰状细胞性贫血测试和筛检市场：依测试方法、按年龄层、按行业、按地区Sickle Cell Anemia Testing and Screening Market, By Testing Method (Hemoglobin Electrophoresis, High-Performance Liquid Chromatography, Point-of-Care Tests, Genetic Testing, and Others), By Age Group, By Sector, By Geography |
||||||
预计2024年全球镰状细胞贫血检测和筛检市场规模为4.652亿美元，预计到2031年将达到10.281亿美元，2024年至2031年的复合年增长率为12%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2023年 | 2024年市场规模 | 4.652 亿美元 |
| 实际资料 | 2019-2023 | 预测期 | 2024-2031 |
| 预测 2024-2031 年复合年增长率： | 12.00% | 2031年价值预测 | 10.281 亿美元 |
镰状细胞性贫血是一种遗传性血液疾病，其中红血球变成C形或镰状。镰状细胞性贫血是一组红血球畸形导致贫血的疾病。这种疾病在撒哈拉以南非洲、拉丁美洲、中美洲和印度血统的人中更为常见。随着全球移民和旅行的增加，这种疾病在不同人群中的盛行率也在增加。早期筛检计画可以帮助控制这种疾病，并透过终身治疗和监测预防併发症。
市场动态：
全球镰状细胞性贫血检测和筛检市场是由这种遗传性血液疾病在全球范围内日益流行所推动的。 2021年10月，世界卫生组织(WHO)估计，每年有超过30万名儿童出生时患有镰状细胞性贫血。高风险族群意识的提高以及将筛检纳入产前检测正在为市场创造利润丰厚的机会。然而，新兴市场的低采用率和认知度继续限制市场成长。精准医疗和非侵入性检测技术的发展将有助于克服挑战并在预测期内进一步扩大市场范围。
本研究的主要特点
该报告对全球镰状贫血检测和筛检市场进行了详细分析，并介绍了以 2023 年为基准年的预测期（2024-2031 年）的市场规模和年复合成长率（CAGR%）。
它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
根据公司亮点、产品系列、主要亮点、绩效和策略等参数，了解全球镰状镰状贫血测试和筛检市场的主要企业概况。
本研究涵盖的主要企业包括 Bio-Rad Laboratories, Inc.、Thermo Fisher Scientific Inc.、Quest Diagnostics Incorporated、Agios Pharmaceuticals, Inc.、Bluebird bio, Inc.、PerkinElmer, Inc.、Laboratory Corporation of America Holdings、Global Blood Therapeutics, Inc.、Edvotek Inc.、Maternova Inc.、Hemex Health、CRISPR Therapeutics、Anamol Laboratories Pvt.有限公司、Atlas Medical GmbH 和 Calibre Scientific, Inc.
该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
全球镰状细胞性贫血测试和筛检市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过用于分析全球镰状细胞贫血测试和筛检市场的各种策略矩阵来促进他们的决策。
目录
第一章 研究目的与前提
- 研究目的
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
第三章 市场动态、法规与趋势分析
- 市场动态
- 影响分析
- 主要进展
- 监管场景
- 产品发布/核准
- PEST分析
- 波特分析
- 併购场景
- 产业动态
第 4 章 2019-2031 年镰状贫血检测与筛检的全球市场（依检测方法）
- 血红素电泳
- 高效液相层析（HPLC）
- 就地检验
- 基因检测
- 其他的
第五镰状镰状细胞性贫血检测和筛检的全球市场（按年龄层），2019-2031 年
- 新生儿筛检
- 1-25岁
- 26岁或以上
第六章 2019-2031 年全球镰状细胞贫血检测与筛检市场（依产业划分）
- 政府实验室
- 私人研究所
- 企业研究院
- 官民合作关係(PPP)
第七章2019-2031 年全球镰状细胞贫血检测与筛检市场（按地区）
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第八章 竞争格局
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- Quest Diagnostics Incorporated
- Agios Pharmaceuticals, Inc.
- Bluebird bio, Inc.
- PerkinElmer, Inc.
- Laboratory Corporation of America Holdings
- Global Blood Therapeutics, Inc.
- Edvotek Inc.
- Maternova Inc.
- Hemex Health
- CRISPR Therapeutics
- Anamol Laboratories Pvt. Ltd.
- Atlas Medical GmbH
- Calibre Scientific, Inc.
第九章 分析师建议
- 命运之轮
- 分析师观点
- 一致的机会图
第10章 参考文献与调查方法
- 参考
- 调查方法
- 关于出版商
The global sickle cell anemia testing and screening market is estimated to be valued at USD 465.2 Mn in 2024 and is expected to reach USD 1,028.1 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 12% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 465.2 Mn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
| Forecast Period 2024 to 2031 CAGR: | 12.00% | 2031 Value Projection: | US$ 1,028.1 Mn |
Sickle cell anemia is a genetic blood disorder that affects the red blood cells and causes them to take on a C-like or sickle shape. It is a group of disorders that causes the red blood cells to become misshapen and break down leasing to anemia. The disorder is more common in those with ancestry from sub-Saharan Africa, Latin America, Central America, and India. With increased immigration and travel globally, its prevalence has increased in diverse populations as well. Early screening programs can help in the management of the condition and prevent complications through lifelong treatment and monitoring.
Market Dynamics:
The global sickle cell anemia testing and screening market is driven by the increasing prevalence of the genetic blood disorder globally. In October 2021, as per the World Health Organization (WHO), it is estimated that over 300,000 children are born with sickle cell anemia each year. Growing awareness among at-risk populations and incorporating screening in prenatal testing are providing lucrative opportunities in the market. However, lower adoption and awareness levels in developing regions continues to restrain the market growth. Developments in precision medicine and non-invasive testing techniques can help overcome challenges and further expand the market reach during the forecast period.
Key Features of the Study:
This report provides in-depth analysis of the global sickle cell anemia testing and screening market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global sickle cell anemia testing and screening market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Agios Pharmaceuticals, Inc., Bluebird bio, Inc., PerkinElmer, Inc., Laboratory Corporation of America Holdings, Global Blood Therapeutics, Inc., Edvotek Inc., Maternova Inc., Hemex Health, CRISPR Therapeutics, Anamol Laboratories Pvt. Ltd., Atlas Medical GmbH, and Calibre Scientific, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global sickle cell anemia testing and screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sickle cell anemia testing and screening market
Market Segmentation
- By Testing Method Insights (Revenue, USD Mn, 2019 - 2031)
- Hemoglobin Electrophoresis
- High-Performance Liquid Chromatography (HPLC)
- Point-of-Care Tests
- Genetic Testing
- Others
- By Age Group Insights (Revenue, USD Mn, 2019 - 2031)
- Newborn Screening
- Ages 1 to 25
- Ages 26 and Above
- By Sector Insights (Revenue, USD Mn, 2019 - 2031)
- Government Labs
- Private Labs
- Corporate Labs
- PPP (Public Private Partnerships)
- Regional Insights (Revenue, USD Mn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- Quest Diagnostics Incorporated
- Agios Pharmaceuticals, Inc.
- Bluebird bio, Inc.
- PerkinElmer, Inc.
- Laboratory Corporation of America Holdings
- Global Blood Therapeutics, Inc.
- Edvotek Inc.
- Maternova Inc.
- Hemex Health
- CRISPR Therapeutics
- Anamol Laboratories Pvt. Ltd.
- Atlas Medical GmbH
- Calibre Scientific, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Sickle Cell Anemia Testing and Screening Market, By Testing Method
- Global Sickle Cell Anemia Testing and Screening Market, By Age Group
- Global Sickle Cell Anemia Testing and Screening Market, By Sector
- Global Sickle Cell Anemia Testing and Screening Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Sickle Cell Anemia Testing and Screening Market, By Testing Method, 2019-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hemoglobin Electrophoresis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- High-Performance Liquid Chromatography (HPLC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Point-of-Care Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Genetic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
5. Global Sickle Cell Anemia Testing and Screening Market, By Age Group, 2019-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Newborn Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Ages 1 to 25
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Ages 26 and Above
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
6. Global Sickle Cell Anemia Testing and Screening Market, By Sector, 2019-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Government Labs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Private Labs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Corporate Labs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Public Private Partnerships (PPP)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
7. Global Sickle Cell Anemia Testing and Screening Market, By Region, 2019 - 2031, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Testing Method, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Sector, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Testing Method, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Sector, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Testing Method, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Sector, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Testing Method, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Sector, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Testing Method, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Sector, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Testing Method, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Sector, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country /Region, 2019 - 2031, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Quest Diagnostics Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agios Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bluebird bio, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PerkinElmer, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Laboratory Corporation of America Holdings
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Global Blood Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Edvotek Inc.
- Maternova Inc.
- Hemex Health
- CRISPR Therapeutics
- Anamol Laboratories Pvt. Ltd.
- Atlas Medical GmbH
- Calibre Scientific, Inc.
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
